Dr. Reddy’s Makes Strategic Move Into Turkey Through Biosimilars
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy’s, one of India’s leading pharmaceutical companies, has entered into a strategic alliance with TR-Pharm to enter the Turkish market, in a deal that includes three biosimilars from the Indian firm and is part of its ongoing push into global emerging markets.